Carmel Pharma Introduces PhaSeal® Secondary Set (C60)
New Component Streamlines Safe Spiking, Priming and IV Bag Infusion with Hazardous Drugs
Columbus, OH (Vocus) October 31, 2009 -- Carmel Pharma, maker of the PhaSeal System for the safe handling
of hazardous drugs, now offers the Secondary Set (C60) for safe, streamlined preparation and administration of
IV bag infusions.
For safety and ease of use, the non-vented Secondary Set offers the following features:
• Drip chamber (20 drops/mL)
• Flow stop to facilitate priming of the Secondary Set from the bag prior to adding the drug
• Universal spike with built-in PhaSeal Connector for safe, leakproof transfer of the drug to the IV bag
• DEHP-free PVC tubing (40 in.)
For more information or to order, call 866-487-9250 or visit www.PhaSeal.com.
PhaSeal is more than a system for the safe handling of hazardous drugs. It's the only clinically proven
closed-system drug transfer device (CSTD) available today and is validated by more than 10 independent,
peer-reviewed, published clinical studies. Distinguished by prominent thought leaders as the "Gold Standard" in
safe handling, PhaSeal's airtight Expansion Chamber and leakproof Double Membrane connections prevent
exposure to hazardous drugs, including aerosols and vapors, and make it the only system that meets the National
Institute for Occupational Safety and Health (NIOSH) and International Society of Oncology Pharmacy
Practitioners (ISOPP) definition of a true CSTD. Its streamlined design and universally-compatible components
make the system easy to use from preparation and administration to waste disposal.
The PhaSeal System is manufactured by Carmel Pharma AB in Gothenburg, Sweden and is distributed from its
U.S. affiliate office, Carmel Pharma, Inc., in Columbus, OH. PhaSeal has been in use in the United States since
1998 and implemented in more than 1000 cancer facilities, infusion centers and private practices, including M.D.
Anderson and Texas Children's in Houston, TX; Cit